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Background: Malignant myoepithelioma is a relatively rare malignant tumor occurring most frequently in the
salivary glands. A few isolated cases have been described in other locations, including soft tissue, bone, lung,
bronchus, oral cavity, nasopharynx, larynx, and maxillary sinus. Malignant myoepithelioma, however, is uncommonly
involved within the cavernous sinus. To the best of our knowledge, this is the first report of malignant
myoepithelioma arising from within the cavernous sinus.
Case presentation: Herein, we report a case of a 48-year-old woman who presented a 1-month history of diplopia
and blepharoptosis as well as radiological evidence of a rapidly developing cavernous sinus tumor. The patient
underwent a trans-sphenoidal biopsy and a histological diagnosis indicated a malignant myoepithelioma. After
diagnosis, the tumor grew rapidly and her clinical condition deteriorated progressively. Therefore, a pterional
craniotomy with partial tumor removal was performed. The patient’s clinical state was worsened, and she died two
months after the initial operation. Because the malignant myoepithelioma could not be traced to an organ of
origin, other than the cavernous sinus, this case was diagnosed as a primary intracranial malignant myoepithelioma.
Conclusion: The purpose of presenting this case report is to raise awareness among clinicians to consider
malignant myoepithelioma as a differential diagnosis when a cavernous sinus mass is identified. Furthermore, an
ideal management strategy for malignant myoepithelioma is not known and the prognosis seems to be
unfavorable; therefore, more cases are needed to enhance our knowledge of the diagnosis, treatment, and
prognosis of this rare intracranial lesion.
Keywords: Myoepithelioma, Cavernous sinus, Treatment, PathologyBackground
Malignant myoepithelioma, also called myoepithelial car-
cinoma, is a malignant tumor that usually occurs in the
salivary glands. It contains markedly proliferating
myoepithelial cells, which are normally present in the sal-
ivary, mammary, and sweat glands [1,2]. Less commonly,
these tumors have been found in the soft tissue [3], bone
[4], lung [5], bronchus [6], oral cavity [7,8], nasopharynx
[9], larynx [10], and maxillary sinus [11]. However, pri-
mary intracranial myoepithelioma is extremely rare, and
only two cases have been described according to our lit-
erature search. Neither of these reported cases involved* Correspondence: wuqun30639@sina.cn
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reproduction in any medium, provided the orthe cavernous sinus. Here, we report a rare case of malig-
nant myoepithelioma in the cavernous sinus and discuss
its clinical, histopathological, and immunohistochemical
features, as well as its prognosis.
Case presentation
A 48-year-old woman was admitted to our hospital with
symptoms of diplopia and blepharoptosis for one month.
Before being taken to our hospital, the patient had vis-
ited the neurology departments in other hospitals with
the aforementioned symptoms and subsequent Magnetic
Resonance Imaging (MRI) (Figure 1A) and endocrine as-
sessments did not indicate anything abnormal. Although
corticosteroid therapy ameliorated her symptoms, these
symptoms reappeared after drug withdrawal. One month
later, a repeated MRI presented a mass lesion located intd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Coronal MRI scans of malignant myoepithelioma development in the present case. Initial T1-weighted post-contrast images
taken at symptom onset were normal (A). Follow-up images 1 month later depicted a new, left cavernous sinus mass with heterogeneous signal
intensity (B). Preoperative images indicated the tumor mass significantly increased (C). Post-biopsy images displayed more progressive tumor
development, since the tumor filled the left cavernous sinus and extended into the ipsilateral middle fossa (D). Postoperative images presented a
large residue with successive tumor growth (E, F).
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lesion was isointense in T1-weighted MRI sequences
and hypointense in T2-weighted sequences. After intra-
venous contrast agent administration, T1-weighted im-
ages showed intense and inhomogeneous enhancement
of the mass (Figure 1B). She was referred to our hospital
for further evaluation and treatment.
At the time of admission, physical examination of the
patient showed abnormal function in her left eye such as
blepharoptosis, a 4 mm-diameter pupil with light reflex
retardation, limited movement, and visual field loss of
upside, downside, and temporal side, which were consid-
ered to be consequences of homo-side oculomotor and
abducent nerves paralysis caused by mass pressure. Signs
of reduction in pain and touch sensation on the left fore-
head skin were also observed in the physical examin-
ation. No abnormal function from other cranial nerves
was observed. The pituitary hormones test showed noth-
ing unusual. A general examination, including chest CT
scan, abdominal ultrasound exam, bone X-ray, and nasal
endoscopic check did not reveal any primary or meta-
static lesions in other areas.
The preoperative differential diagnosis included pituitary
adenoma invading the cavernous sinus, granulomatous in-
flammation, metastatic brain tumor, and primary malig-
nant tumor arising in the cavernous sinus. Therapeutic
trials of corticosteroid administration are important diag-
nostic tests to differentiate granulomatous inflammation
from other neoplastic lesions in the cavernous sinus [12].As aforementioned, the clinical symptoms of the patient
were partially ameliorated after corticosteroid treatment in
the other hospitals, thus we used corticosteroid therapy
again on her for assisting diagnosis. Corticosteroid therapy
relieved her blepharoptosis, but it did not ameliorate her
other symptoms, such as reduced sensation and pupil
function. Furthermore, the patient felt more severe head-
aches, and the results from another MRI scan indicated a
larger scope of mass than before (Figure 1C). With consid-
eration to a malignant tumor and for making an accurate
diagnosis, we recommended performing an endoscopic
trans-sphenoidal approach biopsy, and the patient and
her family agreed with our suggestion. The biopsy was
performed, and digital pathological specimens of this rub-
bery mass were sent to the Department of Pathology and
Laboratory Medicine at the UCLA Medical Center. The
returned surgical pathology consult report made the final
diagnosis of malignant myoepithelioma. Histological in-
vestigation of specimens revealed a tumor composed of
hyper-cellular, moderately pleomorphic round to polyg-
onal tumor cells with moderate to marked nuclear atypia
and eosinophilic cytoplasm. Mitotic figures were present.
There are areas of hemorrhage and necrosis (Figure 2).
Immunohistochemistry (IHC) demonstrated the tumor
cells were positive for smooth muscle actin (SMA), glial
fibrillary acidic protein (GFAP), S-100, and vimentin
(Figure 3). The MIB-1 (Ki-67) proliferation index of
rhabdoid and spindle-shaped cells were 60%. Staining for
Desmin, EMA, CK5/6, CD138, myosin, HMB45, CD79a,
Figure 2 Histological photomicrographs. Hematoxylin and eosin stain (×50) shows an epithelioid neoplasm composed of hyper-cellular,
moderately pleomorphic round to polygonal tumor cells embedded in a myxoid stroma. There are areas of hemorrhage or necrosis (A).
Hematoxylin and eosin stain (× 400) Higher power magnification demonstrates the cells have round to ovoid nuclei, prominent nucleoli, and
abundant eosinophilic cytoplasm. Mitotic figures are present (B).
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tumor were compatible with malignant myoepithelioma.
The patient was then recommended for postoperative
radiotherapy and chemotherapy. Due to economic rea-
sons, they refused the adjuvant treatment. After biopsy,
her left pupil progressively enlarged to the state of mydria-
sis, while the diameter of her right pupil also gradually in-
creased to 5 mm with a reduction in light reflex. Physical
examination revealed typical symptoms resulting from im-
pacted trigeminal and hypoglossal nerves, including re-
duced facial pain and touch sensation, diminished cornealFigure 3 Immunohistochemical stains. The tumor cells demonstrated im
magnification × 400.reflex, dysphagia, cough, and hoarseness. The general con-
dition of the patient progressively deteriorated. A repeated
MRI showed more severe tumor development, which filled
the left cavernous sinus and extended into the ipsilateral
middle fossa (Figure 1D). Given the lesion’s expansion and
the patient’s clinical deterioration, a pterional craniotomy
for resection of the progressed tumor to relieve intracra-
nial pressure of the patient was performed. Only incom-
plete surgical resection was accomplished because the
tumor extended into the hypothalamus and enclosed the
left cavernous carotid artery. Postoperative MRI presentedmunoreactivity for SMA (A), GFAP (B), S-100 (C), vimentin (D). Original
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This pathological finding was compatible with the initial
biopsy finding,and the final pathological diagnosis was
considered as malignant myoepithelioma of the cavernous
sinus. The patient died two weeks after the second ope-
ration due to rapid clinical deterioration, approximately
four months after onset of the initial symptoms. Autopsy
was not performed.
Discussion
Malignant myoepithelioma is a rare malignant neoplasm
in which the tumor cells show myoepithelial differenti-
ation. They are most often found in salivary glands but
also occur in other tissues and organs, including soft
tissues where they were recently recognized as a distinct
diagnostic entity [13]. Malignant myoepitheliomas of soft
tissue display the same wide range of histologic features as
those of salivary gland origin. It appears that these neo-
plasms are equally common in males and females and
occur in a wide age range with a peak in the third to fifth
decades [14]. Unlike its salivary counterpart, a larger per-
centage of soft tissue myoepithelial tumors demonstrate a
more aggressive histology and show a greater propensity
for metastatic disease [15]. Furthermore, they are distin-
guished from benign myoepitheliomas on the basis of
their cytologic rather than architectural features. They are
infrequently associated with a preexisting benign tumor
but appear to arise de novo [14].
Preoperative diagnosis may be difficult or impossible
for malignant myoepithelioma due to nonspecific clinical
manifestation and imaging characteristics. Histological
examination supplemented with IHC staining studies, is
the most reliable and conclusive method of diagnosis. From
a pathological point-of-view, malignant myoepithelioma
commonly contains marked proliferating myoepithelial
cells, and various morphologically, neoplastic myoepithelial
cells are presented, including spindle, plasmacytoid, clear,
epithelioid and stellate types [16,17]. The presence of
significant atypia, atypical mitotic figure, hemorrhage, and
necrosis has been considered features of malignancy [14].
An immunohistochemical study using a panel of epithelial
and myogenic markers is essential for diagnosing this
tumor. Myoepithelial tumors are characteristically positive
for myoepithelial markers including vimentin, cytokeratin,
SMA, S100 and GFAP [2,14,18].
In this case, the tumor commonly consists of spindle cells
with moderate to marked nuclear atypia. The tumor malig-
nancy is supported by cellular pleomorphism, nuclear
atypia, hemorrhage, necrotic areas, a mitotic activity and a
high proliferative MIB-1 index in the neoplasm under the
light microscope. There are some tumors that also show
similar spindle cell composition, such as parachordoma,
chordoma, extraskeletal myxoid chondrosarcoma, unusual
carcinoma and even chondrosarcoma if a chondroid matrixis present and the sampling is small. Distinguishing malig-
nant myoepithelioma from other tumors is as difficult
radiographically as it is clinically. Therefore, to make the
final diagnosis in the present case, immunohistochemical
studies were necessary. The expression patterns of the epi-
thelial and myogenic markers are somewhat varied in each
case and may reflect the degree of myoepithelial cell differ-
entiation. The combination of SMA, GFAP, S-100, and
vimentin positive cells in these lesions aids in the diagnosis
of malignant myoepithelioma.
Intracranial primary malignant myoepithelioma is
extremely rare and has never been noted within the ca-
vernous sinus. In view of this rare site for malignant
myoepithelioma, we only found two cases reporting intra-
cranial primary malignant myoepithelioma utilizing the
help of Medline and Pubmed. Although some differences
exist between the three cases, we can still explore possible
explanations for the occurrence of this salivary gland
tumor. Carsten Nieder et al. [19] had reported a similar
case with a primary myoepithelial carcinoma in the sellar
region. The tumor in this case showed a longer develop-
mental progression with no invasion into the cavernous
sinus. In addition, Sibel Erdogan et al. [20] described a
case of myoepithelial carcinoma arising in the intracranial
dura outside of the sellar region. In comparison to these
two cases, our case showed a rapid tumor development
(the patient survived only four months from initial onset
of symptoms to death) and a rare invasion into the cavern-
ous sinus.
The origin of the malignant myoepithelioma in the
present case remains obscure. At first, we tried to find
some evidence of an extracranial source with salivary gland
distribution to explain it as a metastatic tumor. However,
with regard to the negative findings in the chest CT scan
and nasal endoscopic check, we excluded possible primary
sources, such as the bronchus, nasopharynx, etc. There-
fore, the primary tumor source in this case is determined
to be the cavernous sinus, while taking into consideration
the occurrence of salivary gland heterotopia. Histologically,
the sellar region is a neighboring site to the oral cavity,
nasopharynx, and larynx, where there are salivary glands
existing. And some known reports presented some sellar
region salivary gland tumors that may be related to salivary
gland rests in the sellar region or pituitary [21,22]. In
addition, a possible origin of multipotential stem cells also
needs to be taken into consideration.
Since intracranial malignant myoepitheliomas are such
a rare entity, effective management strategies have not
been established. Treatment options include surgical re-
section, chemotherapy, radiotherapy, or a combination
of these approaches. Surgical resection is the mainstay
therapy for malignant myoepithelioma, but in some cir-
cumstances it may not be technically feasible due to the
rich vascularity and involvement of the cavernous sinus
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can also be used for malignant myoepithelioma. However,
there is no consensus whether postoperative adjuvant
therapy is even required because the prognosis of this
condition is unclear. Some authors reported radiotherapy
or concurrent chemoradiotherapy is effective for local re-
currence and distant metastasis [23,24]. But other reports
confirmed the lack of effectiveness of this adjuvant treat-
ment for both local and distant recurrences [19,25]. The
overall prognosis of malignant myoepithelioma is poor.
Several studies reported aggressive clinical behaviors for
malignant myoepithelioma. The average metastatic rate
was 47% and the mortality rate was 29% after a mean of
32 months [24]. Some factors have been evaluated as
potential prognostic indicators, including clinical stage,
site and size of the tumor, high proliferative activity, exten-
sive invasion into the surrounding tissue, perineural
permeation, the abnormal presence of nuclear DNA con-
tent, and marked cellular pleomorphism [26]. In our case,
the course of the disease was very unfavorable because
complete tumor resection could not be achieved, radio-
therapy or chemotherapy had not been used, high prolife-
rative activity, and other factors.Conclusion
In conclusion, intracranial malignant myoepithelioma is an
extremely rare or often misdiagnosed lesion. This is the first
reported case of a malignant myoepithelioma arising within
the cavernous sinus. Preoperative diagnosis may be difficult
or impossible due to nonspecific clinical manifestation and
imaging characteristics, thus diagnosis can only be made
postoperatively based on histopathological and immunohis-
tochemical analysis. The purpose of presenting this case re-
port is to raise awareness among clinicians to consider this
clinical entity as a differential diagnosis when a cavernous
sinus mass is identified. Furthermore, ideal management
strategy is not known. Surgical resection has been the ac-
cepted treatment for malignant myoepithelioma. The role
of chemotherapy or radiotherapy, however, is controversial.
The prognosis of malignant myoepithelioma seems to be
unfavorable; therefore, more cases are needed to enhance
our knowledge of the diagnosis, treatment, and prognosis
of this rare intracranial lesion.Consent
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